CHTP under heavy accumulation now My short term target is $4 by end of June. $CHTP is under accumulation by big boys now -- they buy early, wait to see how it shakes out during the day, then buy to the close. I honestly think it will trade between $2.50 - $4 until the FDA comes back with approval. Then, CHTP put the year 1 sales of Nothera at $300-$375 Million. With an industry PE ratio multiply by their earnings on that 300m = about $10-$15 /share. Unless of course they get bought out by a big pharma looking to add new products to their lineup -- then it could fetch $25 in a takeover in my opinion.